Under the stewardship of The Economist editors, this inaugural event on cell and gene therapies takes place on April 24th – 25th 2023 in Brussels, Belgium. The summit convenes stakeholders from a range of industries. These important decision-makers will advance the conversation on expediting transformative products to market.
Cell and gene therapies are redefining the treatment of many diseases, giving hope to patients who previously had no therapeutic options. These treatments can be transformative in the battle against cancer, genetic disorders and rare diseases. In the UK, NICE expects to review 30 new cell and gene therapy products by 2023, with the FDA in the US predicting between 15 and 20 new products will be on the market by 2025. Attendees will learn how healthcare systems and policies need to evolve before these therapies can become mainstream.
Through a series of interactive sessions, industry stakeholders will debate the challenges of bringing these therapies to market — including manufacturing, real-world data collection and their commercial sustainability. The conference programme examines the potential for a healthcare paradigm shift, as public opinion and patient experience evolve.
Here are the top three reasons why you should attend Cell and Gene Therapy Summit:
1. Commercial and policy-focused
This event is distinct from others as it explores industry systems—rather than just science. Pharmaceutical companies will gain a deeper understanding of reimbursement and policy.
2. A timely event
NICE expects to review 30 new cell and gene therapy products in the next year, with the FDA predicting there could be between15 and 20 new products on the market by 2025. Around next spring, some of these will have moved through approval to distributions, proving many practical takeaways for attendees.
3. Simplify the chatter
Under the stewardship of The Economist editors, the inaugural event on cell and gene therapies convenes important decision-makers. Attendees will advance the conversation on how to expedite transformative products to market.
Well, if you’re still giving it a second thought, tickets are selling fast. Go grab yours now, before we run out!